To Steer a Brain in Real Time, You May Not Need to Model It
Closed-loop stimulation has been framed as a modelling problem — understand the dynamics well enough to correct them. A new…
NeuroAI Needs a Definition Before It Needs a Budget
NeuroAI is used to describe everything from brain-inspired chip design to neural decoding. Until the field agrees on what it…
The Humanoid Industry Has a Capacity Problem It Cannot Announce Away
Announced production capacity now runs an order of magnitude ahead of units doing paid work. The constraint is not manufacturing…
Neuro AI’s Best Annotator Is the Person Whose Brain It Is
Neuro AI’s scarcest input is ground truth, and the standard fix — more trained annotators — does not scale. A…
Neuro AI Has a Labelling Problem, Not a Compute Problem
In robotics, a human intervention is simultaneously the failure and the label. In neuro AI, the equivalent label has to…
Toddler Brains Show a Different Signature for Play Than for Screens
Using child-friendly EEG caps during ordinary play, Northwestern researchers found toddlers show lower alpha and higher theta activity while interacting…
Denmark Puts Humanoid Robots on the Supermarket Night Shift
Denmark’s Salling Group is trialling humanoid robots from startup Hive Robots in a Føtex supermarket, teaching them to restock shelves…
One Implant, Two Signals: Restoring Speech and Gesture at the Same Time
A high-density electrode array resting on the cortex has decoded attempted speech and hand gestures simultaneously in people with severe…
Figure’s Helix 2.5 Pushes Humanoid Robots Toward Zero-Shot Generalization
Figure has released Helix 2.5, an AI model for its Figure 03 humanoid that lifted whole-task success in 30 unfamiliar…
A Humanoid Robot Played Live Tennis in Beijing, and That Matters More Than It Looks
Galbot’s ET1 humanoid, the designated robot of the 2026 China Open, took to the court in Beijing against former Chinese…
FDA Brings PD-L1 Blockade Into Resected Stage III dMMR Colon Cancer—With DFS Evidence, Not Yet an OS Answer
The FDA has approved atezolizumab with a fluoropyrimidine and oxaliplatin as adjuvant treatment for completely resected stage III deficient mismatch…